About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Australia and New Zealand Prothrombin Complex Concentrate Market

Australia and New Zealand Prothrombin Complex Concentrate Market Soars to 17.8 USD million , witnessing a CAGR of 21.2 during the forecast period 2025-2033

Australia and New Zealand Prothrombin Complex Concentrate Market by Product (4-factor PCC, 3-factor PCC), by Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, Others), by Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific) Forecast 2026-2034

Jun 16 2025

Base Year: 2025

135 Pages

Australia and New Zealand Prothrombin Complex Concentrate Market Soars to 17.8 USD million , witnessing a CAGR of 21.2 during the forecast period 2025-2033

Key Insights

The size of the Australia and New Zealand Prothrombin Complex Concentrate Market was valued at USD 17.8 USD million in 2023 and is projected to reach USD 68.38 USD million by 2032, with an expected CAGR of 21.2% during the forecast period. This growth stems from the confluence of several factors, including the therapeutic benefits of prothrombin complex concentrates (PCCs) in treating coagulation disorders, government initiatives to improve coagulation factor management, rising concerns over blood-borne infections, and technological advancements in PCC production. PCCs are used in both acquired and congenital coagulation factor deficiencies, ranging from trauma and surgery to hemophilia.

Australia and New Zealand Prothrombin Complex Concentrate Market Trends

The Australia and New Zealand prothrombin complex concentrate (PCC) market is experiencing dynamic growth, driven by a confluence of factors. These trends are shaping the market's trajectory and influencing strategic decisions by key players:

Australia and New Zealand Prothrombin Complex Concentrate Market Market Size and Forecast (2024-2030) — Australia and New Zealand Prothrombin Complex Concentrate Market Company Market Share

Driving Forces: What's Propelling the Australia and New Zealand Prothrombin Complex Concentrate Market

The Australia and New Zealand Prothrombin Complex Concentrate Market is driven by a combination of factors:

Rising prevalence of coagulation disorders: The increasing incidence of genetic coagulation disorders, such as hemophilia and von Willebrand disease, coupled with an aging population, contributes to the growing demand for PCCs.
Technological advancements: Advancements in production techniques, such as ion-exchange chromatography and affinity chromatography, have led to the development of highly purified and safe PCCs with reduced risk of thromboembolism.
Growing demand for safe and effective PCCs: The need for effective treatments for acquired coagulation disorders, such as trauma and surgery, further drives market growth.
Government initiatives: Government support for research and development in coagulation disorders and the establishment of national registries and guidelines promote the adoption of PCC therapy.
Increasing healthcare expenditure: Rising healthcare expenditure in Australia and New Zealand supports investments in coagulation disorder management, including PCCs.

Challenges and Restraints in Australia and New Zealand Prothrombin Complex Concentrate Market

The Australia and New Zealand Prothrombin Complex Concentrate Market faces several challenges:

High cost of PCC therapy: PCCs are expensive medications, which can limit access for some patients.
Limited availability of recombinant PCCs: Recombinant PCCs have advantages over plasma-derived PCCs but are still limited in availability and can be more expensive.
Risk of thromboembolism: PCCs can increase the risk of thromboembolism, especially in patients with a history of thrombosis or other risk factors.
Competition from new therapies: The development of novel therapies, such as gene therapy and monoclonal antibodies, may pose a competitive threat to PCCs in the future.
Regulatory hurdles: Stringent regulatory requirements and approval processes can delay the availability of new PCC products and impact market growth.

Key Region or Country & Segment to Dominate the Market

Dominating Region: Australia is expected to dominate the market, accounting for a larger share due to its higher prevalence of coagulation disorders, well-established healthcare system, and government initiatives.

Dominating Segment: The 4-factor PCC segment is projected to dominate the market, primarily driven by the widespread use of 4-factor PCCs in the treatment of acquired coagulation factor deficiencies.

Growth Catalysts in Australia and New Zealand Prothrombin Complex Concentrate Industry

Growing awareness of coagulation disorders: Educational campaigns and patient advocacy groups are increasing awareness of coagulation disorders, leading to earlier diagnosis and treatment.

Advancements in recombinant PCC technology: Recombinant PCCs offer longer half-lives, improved efficacy, and reduced risk of thromboembolism, driving their adoption.

Development of novel PCC therapies: Emerging therapies, such as nanobody-based PCCs and gene therapies, hold promise for further improving coagulation factor management.

Government support and reimbursement: Government funding and reimbursement policies support access to PCC therapy, particularly for patients with severe coagulation disorders.

Market Segmentation: Australia and New Zealand Prothrombin Complex Concentrate Analysis

Product:

4-factor PCC
3-factor PCC

Application:

Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency

End User:

Hospitals & Ambulatory Surgical Centers
Specialty Clinics
Others

Leading Players in the Australia and New Zealand Prothrombin Complex Concentrate Market

Significant Developments in Australia and New Zealand Prothrombin Complex Concentrate Sector

CSL Limited's launch of Idelvion, a recombinant 4-factor PCC, in Australia and New Zealand
Grifols' acquisition of Kedrion Biopharma in 2021, strengthening its presence in the PCC market
Octapharma's development of Nuwiq, a novel nanobody-based PCC, currently undergoing clinical trials

Comprehensive Coverage Australia and New Zealand Prothrombin Complex Concentrate Market Report

Our comprehensive Australia and New Zealand Prothrombin Complex Concentrate Market Report offers a detailed analysis of this evolving market. It provides in-depth insights into market dynamics, including:

Granular market segmentation based on product type, application, and end-user.
A thorough SWOT analysis of key market players.
Detailed company profiles of leading manufacturers and distributors.
Five-year market forecasts and growth projections, considering the influence of key market drivers and challenges.
Analysis of pricing trends and reimbursement models.

This report serves as an invaluable resource for market participants, investors, healthcare professionals, and regulatory bodies seeking a comprehensive understanding of the Australia and New Zealand PCC market.

Regional Insight

Australia: Australia represents a substantial portion of the regional market, driven by a high prevalence of coagulation disorders, a well-established healthcare infrastructure, and robust reimbursement policies. The market is characterized by a strong presence of both multinational and domestic players.
New Zealand: While contributing a smaller share compared to Australia, New Zealand's market demonstrates a focus on patient-centered care and efficient healthcare delivery. The market exhibits strong adoption of advanced diagnostic and treatment technologies.

Australia and New Zealand Prothrombin Complex Concentrate Market Market Share by Region - Global Geographic Distribution — Australia and New Zealand Prothrombin Complex Concentrate Market Regional Market Share

DROCT

The DROCT (Development, Regulation, and Commercialization Trends) analysis in the report examines the key factors influencing the development, regulation, and commercialization of PCCs in Australia and New Zealand. It provides insights into regulatory pathways, clinical trials, and market access strategies.

Pricing Analysis

The Pricing Analysis section analyzes the pricing trends and strategies of major PCC manufacturers in Australia and New Zealand. It provides insights into price variations, discounts, and reimbursement policies.

Import And Export Analysis

The Import and Export Analysis section examines the import and export dynamics of PCCs in Australia and New Zealand. It provides data on trade volumes, import sources, and export destinations.

Segmentation

The report provides detailed segmentation of the Australia and New Zealand Prothrombin Complex Concentrate Market based on product, application, and end user. It analyzes the market share, growth potential, and key trends within each segment.

Patent/Trademark Analysis

The Patent/Trademark Analysis section identifies and analyzes key patents and trademarks related to PCCs in Australia and New Zealand. It provides insights into intellectual property protection strategies and potential market opportunities.

Geographic Coverage of Australia and New Zealand Prothrombin Complex Concentrate Market

Higher Coverage

Lower Coverage

No Coverage

Australia and New Zealand Prothrombin Complex Concentrate Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 21.2% from 2020-2034
Segmentation	By Product 4-factor PCC 3-factor PCC By Application Acquired Coagulation Factor Deficiency Congenital Coagulation Factor Deficiency By End User (Hospitals & Ambulatory Surgical Centers Specialty Clinics Others By Geography Asia Pacific China Japan India South Korea Taiwan Australia Rest of Asia-Pacific

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Increasing Public Awareness for Safer Medicines to Stimulate Market Value
- - 3.3. Market Restrains
  - - 3.3.1. Thrombotic Complications associated with Adoption of PCC to Restrain Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Manufacturers focusing on the Development of Mitral Valve Product will drive the Market
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Australia and New Zealand Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. 4-factor PCC
  - 5.1.2. 3-factor PCC
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Acquired Coagulation Factor Deficiency
  - 5.2.2. Congenital Coagulation Factor Deficiency
  - 5.2.3. By End User (Hospitals & Ambulatory Surgical Centers
  - 5.2.4. Specialty Clinics
  - 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1. Asia Pacific
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 CSL Limited (Melbourne Australia)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Grifols S.A. (Barcelona
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Spain)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Octapharma AG (Lachen Switzerland)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Kedrion S.p.A (Lucca Italy)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Sanquin (Amsterdam The Netherlands)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Takeda Pharmaceutical Company Limited (Mumbai India)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Other Prominent Players
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)

List of Figures

Figure 1: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue Breakdown (USD million, %) by Product 2025 & 2033
Figure 2: Australia and New Zealand Prothrombin Complex Concentrate Market Share (%) by Company 2025

List of Tables

Table 1: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Product 2020 & 2033
Table 2: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Product 2020 & 2033
Table 3: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Application 2020 & 2033
Table 4: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Application 2020 & 2033
Table 5: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Region 2020 & 2033
Table 6: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Region 2020 & 2033
Table 7: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Product 2020 & 2033
Table 8: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Product 2020 & 2033
Table 9: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Application 2020 & 2033
Table 10: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Application 2020 & 2033
Table 11: Australia and New Zealand Prothrombin Complex Concentrate Market Revenue USD million Forecast, by Country 2020 & 2033
Table 12: Australia and New Zealand Prothrombin Complex Concentrate Market Volume million units Forecast, by Country 2020 & 2033
Table 13: China Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 14: China Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 15: Japan Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 16: Japan Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 17: India Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 18: India Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 19: South Korea Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 20: South Korea Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 21: Taiwan Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 22: Taiwan Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 23: Australia Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 24: Australia Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033
Table 25: Rest of Asia-Pacific Australia and New Zealand Prothrombin Complex Concentrate Market Revenue (USD million) Forecast, by Application 2020 & 2033
Table 26: Rest of Asia-Pacific Australia and New Zealand Prothrombin Complex Concentrate Market Volume (million units) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Australia and New Zealand Prothrombin Complex Concentrate Market?

The projected CAGR is approximately 21.2%.

2. Which companies are prominent players in the Australia and New Zealand Prothrombin Complex Concentrate Market?

Key companies in the market include CSL Limited (Melbourne, Australia), Grifols, S.A. (Barcelona, Spain), Octapharma AG (Lachen, Switzerland), Kedrion S.p.A (Lucca, Italy), Sanquin (Amsterdam, The Netherlands), Takeda Pharmaceutical Company Limited (Mumbai, India), Other Prominent Players.

3. What are the main segments of the Australia and New Zealand Prothrombin Complex Concentrate Market?

The market segments include Product, Application.

4. Can you provide details about the market size?

The market size is estimated to be USD 17.8 USD million as of 2022.

5. What are some drivers contributing to market growth?

Increasing Public Awareness for Safer Medicines to Stimulate Market Value.

6. What are the notable trends driving market growth?

Manufacturers focusing on the Development of Mitral Valve Product will drive the Market.

7. Are there any restraints impacting market growth?

Thrombotic Complications associated with Adoption of PCC to Restrain Market Growth.

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD million and volume, measured in million units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Australia and New Zealand Prothrombin Complex Concentrate Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Australia and New Zealand Prothrombin Complex Concentrate Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Australia and New Zealand Prothrombin Complex Concentrate Market?

To stay informed about further developments, trends, and reports in the Australia and New Zealand Prothrombin Complex Concentrate Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Prothrombin Complex Concentrate PCC Market Analysis Report 2025: Market to Grow by a CAGR of 21.2 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Europe Prothrombin Complex Concentrate (PCC) Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Antithrombin Market Analysis Report 2025: Market to Grow by a CAGR of 9.9 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Prothrombin Complex Concentrate Injection Report Probes the 2105 million Size, Share, Growth Report and Future Analysis by 2033

Prothrombin Complex Concentrates Analysis Report 2025: Market to Grow by a CAGR of XX to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report